The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Tadalafil Generics ((previously known Tadalafil Mylan Pharma))

Viatris LimitedEU/1/16/1153/001-004

Main Information

Trade NameTadalafil Generics ((previously known Tadalafil Mylan Pharma))
Active SubstancesTadalafil
Dosage FormFilm-coated tablet
Licence HolderViatris Limited
Licence NumberEU/1/16/1153/001-004

Group Information

ATC CodeG04BE Drugs used in erectile dysfunction
G04BE08 tadalafil


License statusAuthorised
Licence Issued09/01/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back